NASDAQ: AIFFFirefly Neuroscience Inc Stock
$4.25+0.79 (+22.83%)
Updated Mar 14, 2025
AIFF Price
$4.25
Fair Value Price
N/A
Market Cap
$36.14M
52 Week Low
$1.86
52 Week High
$17.20
P/E
-1.3x
P/B
13.02x
P/S
3.79x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.68M
Earnings
-$6.12M
Gross Margin
35.5%
Operating Margin
-107.48%
Profit Margin
-107.7%
Debt to Equity
0.91
Operating Cash Flow
-$5M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AIFF Overview
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AIFF's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Information Technology Service
Industry Rating
A
AIFF
Ranked#48 of 60
Ranked#48 of 60
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $24.86 | A | |
| $13.88 | A | |
| $104.43 | A |
Be the first to know about important AIFF news, forecast changes, insider trades & much more!
AIFF News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AIFF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AIFF is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AIFF is poor value based on its book value relative to its share price (13.02x), compared to the US Information Technology Services industry average (5.09x)
P/B vs Industry Valuation
AIFF is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AIFF due diligence checks available for Premium users.
Valuation
AIFF price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.3x
Industry
28.61x
Market
3,446.61x
AIFF price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
13.02x
Industry
5.09x
AIFF is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AIFF's financial health
Profit margin
Revenue
$33.0k
Net Income
-$4.3M
Profit Margin
-12,997%
AIFF's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AIFF's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.3M
Liabilities
$2.5M
Debt to equity
0.91
AIFF's short-term assets ($2.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AIFF's short-term assets ($2.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AIFF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AIFF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.7M
Investing
-$401.0k
Financing
$4.6M
AIFF's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AIFF vs Information Technology Service Stocks
Firefly Neuroscience Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.